| Kieri L Olmstead, MS, S-MFT | |
|
3601 Main St, Kansas City, MO 64111-1908 | |
| (816) 200-7266 | |
| Not Available |
| Full Name | Kieri L Olmstead |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 3601 Main St, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326559196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kieri L Olmstead, MS, S-MFT 1216 Sw Sapperton Rd, Lees Summit, MO 64083-3803 Ph: (913) 200-5546 | Kieri L Olmstead, MS, S-MFT 3601 Main St, Kansas City, MO 64111-1908 Ph: (816) 200-7266 |
News Archive
Physicians currently evaluate a patient's risk for heart disease, stroke and other cardiovascular diseases (CVD) individually, but a new assessment tool could gauge risk of overall 'or global' CVD and a range of cardiovascular diseases at one time, according to a study published in Circulation: Journal of the American Heart Association.
Aeterna Zentaris Inc., today announced that an interim review of a Phase 3 trial of AEZS-130 (macimorelin, SolorelTM), demonstrates the compound may provide a simple, well-tolerated and safe oral diagnostic test for Adult Growth Hormone Deficiency (AGHD). The data was presented earlier today by Beverly M.K. Biller, M.D. of the Harvard Medical School/Massachusetts General Hospital in Boston, at the 5th International Congress of the Growth Hormone Research Society (GRS) and the Insulin-like Growth Factors (IGF) Society in New York City.
Cambridge Enterprise has exclusively licensed intellectual property relating to the use of PARP inhibitor drugs for treating vascular disease to CYCLE Pharmaceuticals.
Create a picture of how you are feeling on this particular day, said the first exercise in the art therapy. After ten treatments the patients who suffered from severe or moderately severe depression had shown more improvement than the patients in the control group, shows research at Sahlgrenska academy.
Scientists are continuing their work on the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination trial — known more commonly as the BATTLE trial — and presented updated results at the AACR 102nd Annual Meeting 2011, held here April 2-6.
› Verified 6 days ago
Katie Ballard, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3743 Main St, Kansas City, MO 64111 Phone: 816-806-7107 | |
Jerome Alexander Hawkins, S-MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3601 Main St, Kansas City, MO 64111 Phone: 816-729-5533 | |
Halee Winfrey, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 118 Southwest Blvd Ste 300, Kansas City, MO 64108 Phone: 816-226-7366 | |
Amanda L Rexwinkle, LCMFT, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5736 N Broadway St, Kansas City, MO 64118 Phone: 816-866-6053 | |
Mr. Jeffery M Sumler, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7611 State Line Rd, Ste. 142, Kansas City, MO 64114 Phone: 816-763-7605 Fax: 816-763-1802 | |
Mrs. Shara Adrianne Mcglothan, PLMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 107 W 9th St Unit 322, Kansas City, MO 64105 Phone: 816-974-7025 | |
Martha Jolene Boyd, M.S., LPC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 620 E 18th St, Kansas City, MO 64108 Phone: 816-445-4285 |